Translational biology of osteosarcoma

被引:1017
作者
Kansara, Maya [1 ,2 ]
Teng, Michele W. [3 ,4 ,5 ]
Smyth, Mark J. [3 ,4 ,5 ]
Thomas, David M. [1 ,2 ,6 ]
机构
[1] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic 3002, Australia
[2] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3010, Australia
[3] OIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Brisbane, Qld 4006, Australia
[4] OIMR Berghofer Med Res Inst, Canc Immunoregulat & Immunotherapy Lab, Brisbane, Qld 4006, Australia
[5] Univ Queensland, Sch Med, Herston, Qld 4006, Australia
[6] St Vincents Hosp, Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW 2010, Australia
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
HIGH-GRADE OSTEOSARCOMA; CHILDRENS ONCOLOGY GROUP; RAPAMYCIN INHIBITOR RIDAFOROLIMUS; COMPARATIVE GENOMIC HYBRIDIZATION; PRECLINICAL TESTING PROGRAM; ROTHMUND-THOMSON-SYNDROME; COLONY-STIMULATING FACTOR; TUMOR-REJECTION ANTIGEN; MESENCHYMAL STEM-CELLS; GROWTH-FACTOR-I;
D O I
10.1038/nrc3838
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
For the past 30 years, improvements in the survival of patients with osteosarcoma have been mostly incremental. Despite evidence of genomic instability and a high frequency of chromothripsis and kataegis, osteosarcomas carry few recurrent targetable mutations, and trials of targeted agents have been generally disappointing. Bone has a highly specialized immune environment and many immune signalling pathways are important in bone homeostasis. The success of the innate immune stimulant mifamurtide in the adjuvant treatment of non-metastatic osteosarconna suggests that newer immune-based treatments, such as immune checkpoint inhibitors, may substantially improve disease outcome.
引用
收藏
页码:722 / 735
页数:14
相关论文
共 208 条
  • [1] Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy
    Ahmed, Mahiuddin
    Cheung, Nai-Kong V.
    [J]. FEBS LETTERS, 2014, 588 (02): : 288 - 297
  • [2] Decitabine-induced demethylation of 5′ CpG island in GADD45A leads to apoptosis in osteosarcoma cells
    Al-Romaih, Khaldoun
    Sadikovic, Bekim
    Yoshimoto, Maisa
    Wang, Yuzhuo
    Zielenska, Maria
    Squire, Jeremy A.
    [J]. NEOPLASIA, 2008, 10 (05): : 471 - 480
  • [3] Mifamurtide in Metastatic and Recurrent Osteosarcoma: A Patient Access Study With Pharmacokinetic, Pharmacodynamic, and Safety Assessments
    Anderson, P. M.
    Meyers, P.
    Kleinerman, E.
    Venkatakrishnan, K.
    Hughes, D. P.
    Herzog, C.
    Huh, W.
    Sutphin, R.
    Vyas, Y. M.
    Shen, V.
    Warwick, A.
    Yeager, N.
    Oliva, C.
    Wang, B.
    Liu, Y.
    Chou, A.
    [J]. PEDIATRIC BLOOD & CANCER, 2014, 61 (02) : 238 - 244
  • [4] [Anonymous], 1910, P R SOC MED, DOI DOI 10.1177/003591571000301601
  • [5] [Anonymous], 2013, WHO classification of tumours of soft tissue and bone, P281
  • [6] Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group
    Arndt, Carola A. S.
    Koshkina, Nadya V.
    Inwards, Carrie Y.
    Hawkins, Douglas S.
    Krailo, Mark D.
    Villaluna, Doojduen
    Anderson, Peter M.
    Goorin, Allen M.
    Blakely, Martin L.
    Bernstein, Mark
    Bell, Sharon A.
    Ray, Kaylee
    Grendahl, Darryl C.
    Marina, Neyssa
    Kleinerman, Eugenie S.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (15) : 4024 - 4030
  • [7] Gene amplifications in osteosarcoma -: CGH microarray analysis
    Atiye, J
    Wolf, M
    Kaur, S
    Monni, O
    Böhling, T
    Kivioja, A
    Tas, É
    Serra, M
    Tarkkanen, M
    Knuutila, S
    [J]. GENES CHROMOSOMES & CANCER, 2005, 42 (02) : 158 - 163
  • [8] Genomic mechanisms and measurement of structural and numerical instability in cancer cells
    Bayani, Jane
    Selvarajah, Shamini
    Maire, Georges
    Vukovic, Bisera
    Al-Romaih, Khaldoun
    Zielenska, Maria
    Squire, Jeremy A.
    [J]. SEMINARS IN CANCER BIOLOGY, 2007, 17 (01) : 5 - 18
  • [9] INTERFERONS AND BONE - A COMPARISON OF THE EFFECTS OF INTERFERON-ALPHA AND INTERFERON-GAMMA IN CULTURES OF HUMAN BONE-DERIVED CELLS AND AN OSTEOSARCOMA CELL-LINE
    BERESFORD, JN
    TAYLOR, GT
    TRIFFITT, JT
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 193 (02): : 589 - 597
  • [10] 153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patients
    Berger, M.
    Grignani, G.
    Giostra, A.
    Ferrari, S.
    Ferraresi, V.
    Tamburini, A.
    Cefalo, G.
    Carnevale-Schianca, F.
    Vassallo, E.
    Picci, P.
    Pagano, M.
    Aglietta, M.
    Pellerito, R. E.
    Fagioli, F.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (07) : 1899 - 1905